Valuation GSK plc NYSE

Stocks

Market Closed - NYSE Other stock markets 16:00:02 2026-07-06 EDT			After hours 20:00:00
53.09 ^USD	-1.06%		49.24	-7.26%

07-06	Stocks mixed as weak miners weigh in muted trade	AN
07-06	HSBC Upgrades GSK to Hold Rating, Boosts PT	MT

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	80,458	58,381	59,112	54,944	73,201	79,016	-	-
Change	-	-27.44%	1.25%	-7.05%	33.23%	7.94%	-	-
Enterprise Value (EV) ¹	100,296	75,578	74,152	68,039	87,654	94,449	91,256	88,065
Change	-	-24.65%	-1.89%	-8.24%	28.83%	7.75%	-3.38%	-3.5%
P/E	18.6x	3.93x	11.9x	21.3x	12.9x	12.7x	11.7x	11.6x
PBR	5.34x	5.47x	4.4x	4.02x	-	4.58x	3.82x	3.3x
PEG	-	0x	-0.2x	-0.4x	0x	1.2x	1.33x	10.97x
Capitalization / Revenue	2.36x	1.99x	1.95x	1.75x	2.24x	2.33x	2.22x	2.15x
EV / Revenue	2.94x	2.58x	2.45x	2.17x	2.68x	2.79x	2.56x	2.4x
EV / EBITDA	8.85x	7.23x	6.37x	6.36x	7.77x	8.16x	7.37x	6.98x
EV / EBIT	11.4x	9.27x	8.44x	7.44x	8.96x	9.24x	8.28x	7.68x
EV / FCF	22.6x	12.1x	13.6x	13x	13.7x	16.6x	15x	13.7x
FCF Yield	4.42%	8.28%	7.36%	7.67%	7.32%	6.01%	6.67%	7.32%
Dividend per Share ²	1	0.6125	0.58	0.61	0.66	0.6968	0.7336	0.7663
Rate of return	4.98%	4.26%	4%	4.53%	3.62%	3.51%	3.7%	3.86%
EPS ²	1.082	3.662	1.216	0.632	1.411	1.558	1.695	1.713
Distribution rate	92.4%	16.7%	47.7%	96.5%	46.8%	44.7%	43.3%	44.7%
Net sales ¹	34,114	29,324	30,328	31,376	32,667	33,860	35,583	36,679
EBITDA ¹	11,330	10,449	11,635	10,693	11,278	11,571	12,378	12,617
EBIT ¹	8,806	8,151	8,786	9,148	9,783	10,220	11,028	11,466
Net income ¹	4,385	14,956	4,928	2,575	5,716	6,471	6,935	6,809
Net Debt ¹	19,838	17,197	15,040	13,095	14,453	15,433	12,240	9,050
Reference price ²	20.08	14.38	14.50	13.46	18.24	19.83	19.83	19.83
Nbr of stocks (in thousands)	4,006,383	4,060,999	4,076,145	4,080,519	4,012,126	3,984,652	-	-
Announcement Date	2/9/22	2/1/23	1/31/24	2/5/25	2/4/26	-	-	-

¹GBP in Million²GBP

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
ELI LILLY AND COMPANY	35.49x	12.89x	26.26x	0.56%	1,070B
JOHNSON & JOHNSON	28.11x	6.46x	17.57x	2.03%	624B
ABBVIE INC.	32.2x	7.69x	15.73x	2.65%	450B
ROCHE HOLDING AG	18.15x	4.51x	11.08x	2.94%	328B
ASTRAZENECA PLC	24.06x	5.03x	14.1x	1.73%	292B
NOVARTIS AG	22.19x	5.69x	13.74x	2.76%	284B
NOVO NORDISK A/S	14.43x	5.37x	11.03x	3.47%	217B
AMGEN INC.	24.39x	6.45x	11.36x	2.7%	198B
GILEAD SCIENCES, INC.	-46.87x	5.66x	31.47x	2.47%	161B
Average	16.90x	6.64x	16.92x	2.37%	402.71B
Weighted average by Cap.	24.75x	8.06x	18.63x	1.93%